Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (181-190 of 329) with videos related to

Pageof 33
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic driversMichaël Duruisseaux, Martine Antoine, Nathalie Rabbe, et al.
AIDS (London, England)|July 1, 2015
Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control studyMathias Bruyand, Fabien Le Marec, Armelle Lavole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patientsMagid Herida, Murielle Mary-Krause, Régis Kaphan, et al.
Annals of the American Thoracic Society|December 14, 2023
Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary FibrosisLucile Sesé, Raphaël Borie, Caroline Kannengiesser, et al.
Respiratory Medicine and Research|October 28, 2023
Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumoniaAlice Letellier, Camille Rolland-Debord, David Luque-Paz, et al.
Plos One|June 2, 2012
Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma: results of the IFCT-0504-Epidemio studyDelphine Lutringer-Magnin, Nicolas Girard, Jacques Cadranel, et al.
The European Respiratory Journal|March 24, 2012
Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosisAbdellatif Tazi, Karima Marc, Stéphane Dominique, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Characterization of lung cancers in patients with BRCA germline variants: A multicenter seriesMateo Sanchis-Borja, Vincent Fallet, Elisabeth Fabre, et al.
ESMO Open|August 11, 2018
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)Jaafar Bennouna, Fabrice Barlesi, Pascal Do, et al.
The Journal of Pathology|May 21, 2011
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinomaAmandine Hurbin, Marie Wislez, Benoît Busser, et al.
Pageof 33

Showing results (181-190 of 329) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic driversMichaël Duruisseaux, Martine Antoine, Nathalie Rabbe, et al.
AIDS (London, England)|July 1, 2015
Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control studyMathias Bruyand, Fabien Le Marec, Armelle Lavole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patientsMagid Herida, Murielle Mary-Krause, Régis Kaphan, et al.
Annals of the American Thoracic Society|December 14, 2023
Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary FibrosisLucile Sesé, Raphaël Borie, Caroline Kannengiesser, et al.
Respiratory Medicine and Research|October 28, 2023
Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumoniaAlice Letellier, Camille Rolland-Debord, David Luque-Paz, et al.
Plos One|June 2, 2012
Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma: results of the IFCT-0504-Epidemio studyDelphine Lutringer-Magnin, Nicolas Girard, Jacques Cadranel, et al.
The European Respiratory Journal|March 24, 2012
Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosisAbdellatif Tazi, Karima Marc, Stéphane Dominique, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Characterization of lung cancers in patients with BRCA germline variants: A multicenter seriesMateo Sanchis-Borja, Vincent Fallet, Elisabeth Fabre, et al.
ESMO Open|August 11, 2018
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)Jaafar Bennouna, Fabrice Barlesi, Pascal Do, et al.
The Journal of Pathology|May 21, 2011
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinomaAmandine Hurbin, Marie Wislez, Benoît Busser, et al.
Pageof 33